Tumour-associated CD8+ cells uniformly expressed the activation marker CD69 (ref. 23), but displayed variable levels of the inhibitory receptors PD1 and T-cell immunoglobulin domain and mucin domain 3 (TIM3)24. The gene discussed is CD8A; the disease is neoplasm.